Brief: Alstrosight: Joint Project Between Theranexus, Inria, Claude Bernard University Lyon 1 And Hospices Civils De Lyon
Feb 10 (Reuters) - Theranexus SA ALTHX.PA :
* THERANEXUS, INRIA, CLAUDE BERNARD UNIVERSITY LYON 1 AND
HOSPICES
CIVILS DE LYON TODAY ANNOUNCED LAUNCH OF NEW PUBLIC-PRIVATE
PROJECT TEAM "ALSTROSIGHT"
* PROJECT TEAM AIMS TO DEVELOP INNOVATIVE DIGITAL METHODS TO
IDENTIFY NEW DRUG CANDIDATES DESIGNED TO TREAT BRAIN DISEASES,
IN PARTICULAR CERTAIN RARE NEUROLOGICAL DISORDERS.
* PROJECT TEAM, LAUNCHED IN JANUARY 2023, WILL BE LED OVER
AN
INITIAL 4-YEAR PERIOD
Source text for Eikon: ID:nACT78525
Further company coverage: ALTHX.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Thx Pharma SA
See all newsBrief: Theranexus And BBDF Announce Final And Positive Safety And Efficacy Data In The Phase I/II Trial Testing Batten-1
Brief: Theranexus End-Dec Total Available Funds Stood At EUR 4.9 Mln
Brief: Theranexus Declares Encouraging Prelim Results For Batten Disease Drug
Brief: Theranexus And BBDF Granted Positive Opinion By EMA For Design Of Batten-1 Phase III Trial
Brief: Theranexus And BBDF Win FDA Approval On Endpoints For Phase III Trial To Evaluate Batten-1 In CLN3 Batten Disease